Teva Pharmaceutical Industries Limited (BVMF:T1EV34)

Market Cap	200.60B
Revenue (ttm)	89.41B
Net Income (ttm)	3.80B
Shares Out	n/a
EPS (ttm)	3.29
PE Ratio	52.79
Forward PE	12.03
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5
Average Volume	196
Open	84.48
Previous Close	82.88
Day's Range	84.48 - 84.48
52-Week Range	39.30 - 84.48
Beta	0.67
RSI	80.91
Earnings Date	Jan 28, 2026

About BVMF:T1EV34

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The com...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1901
• Employees: 35,686
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: T1EV34

Financial Performance

In 2024, BVMF:T1EV34's revenue was $16.54 billion, an increase of 4.40% compared to the previous year's $15.85 billion. Losses were -$1.64 billion, 193.2% more than in 2023.

Financial numbers in USD